AU2001273318A1 - Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disorders - Google Patents

Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disorders

Info

Publication number
AU2001273318A1
AU2001273318A1 AU2001273318A AU7331801A AU2001273318A1 AU 2001273318 A1 AU2001273318 A1 AU 2001273318A1 AU 2001273318 A AU2001273318 A AU 2001273318A AU 7331801 A AU7331801 A AU 7331801A AU 2001273318 A1 AU2001273318 A1 AU 2001273318A1
Authority
AU
Australia
Prior art keywords
diagnosing
disorders
compositions
methods
treating preeclampsia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001273318A
Inventor
James C. Keith Jr.
John M Mccoy
Sha Mi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute LLC filed Critical Genetics Institute LLC
Publication of AU2001273318A1 publication Critical patent/AU2001273318A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/368Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001273318A 2000-07-07 2001-07-09 Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disorders Abandoned AU2001273318A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21665700P 2000-07-07 2000-07-07
US60/216,657 2000-07-07
PCT/US2001/021719 WO2002004678A2 (en) 2000-07-07 2001-07-09 Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disorders

Publications (1)

Publication Number Publication Date
AU2001273318A1 true AU2001273318A1 (en) 2002-01-21

Family

ID=22807962

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001273318A Abandoned AU2001273318A1 (en) 2000-07-07 2001-07-09 Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disorders

Country Status (3)

Country Link
US (1) US20020102530A1 (en)
AU (1) AU2001273318A1 (en)
WO (1) WO2002004678A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1583846B1 (en) * 2003-01-17 2011-11-16 The Chinese University Of Hong Kong Circulating mrna as diagnostic markers for pregnancy-related disorders
WO2005017192A2 (en) * 2003-08-14 2005-02-24 The General Hospital Corporation Screening for gestational disorders
EP1664797B1 (en) * 2003-09-23 2015-11-11 The General Hospital Corporation Screening for preeclampsia
CA2563704A1 (en) 2004-05-04 2005-11-24 Children's Medical Center Corporation Methods and compositions for treatment of preeclampsia
WO2006069592A2 (en) * 2004-12-31 2006-07-06 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg Method for diagnosing an/or predicting preeclampsia and/or related disorders
US20060212484A1 (en) * 2005-03-18 2006-09-21 Chaffin David G Jr System and method for evaluating, monitoring, diagnosing, and treating hypertension and other medical disorders
US7718367B2 (en) * 2005-03-18 2010-05-18 The Chinese University Of Hong Kong Markers for prenatal diagnosis and monitoring
EP1914552A1 (en) * 2006-10-20 2008-04-23 The University Of Newcastle Research Associates Limited Method for identifying women with an increased risk of pre-eclampsia
WO2008134881A1 (en) * 2007-05-05 2008-11-13 The University Of Western Ontario Methods for the detection of preeclampsia
EP3309178A4 (en) 2015-06-11 2019-05-08 Keio University Fusion protein or conjugated protein, intracellular delivery carrier, partial peptide, cell membrane permeation enhancer, dna, and vector
CN112180098B (en) * 2019-12-06 2023-02-17 中山大学 Screening method of placenta-related disease marker and marker
WO2021207168A1 (en) * 2020-04-06 2021-10-14 The Trustees Of The University Of Pennsylvania Methods for using extracellular micro vesicles with syncytiotrophoblast markers to diagnose preeclampsia
CN113528646A (en) * 2021-07-22 2021-10-22 青岛思拓新源细胞医学有限公司 Diagnosis marker for preeclampsia and application of diagnosis marker in preparation of target spot medicine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE346153T1 (en) * 1997-07-07 2006-12-15 Bio Merieux ENDOGENEOUS RETROVIRAL SEQUENCES, RELATED TO AUTO-IMMUNE DISEASES OR TO PREGNANCY DISORDERS
FR2797889A1 (en) * 1999-09-01 2001-03-02 Bio Merieux METHOD FOR DETECTING THE EXPRESSION OF ENVELOPE PROTEIN FROM A HUMAN ENDOGENEOUS RETROVIRUS AND USES OF A GENE ENCODING SAME

Also Published As

Publication number Publication date
WO2002004678A2 (en) 2002-01-17
WO2002004678A3 (en) 2003-08-07
US20020102530A1 (en) 2002-08-01

Similar Documents

Publication Publication Date Title
WO2005046434A8 (en) Compositions and methods for diagnosing and treating mental disorders
AUPS323902A0 (en) Compositions and methods for treating gynaecological disorders
AU2001285159A1 (en) Methods for treating endocrine disorders
AU8003800A (en) Methods and compositions for treating neurobehavioral disorders
AU2002340120A1 (en) Semisolid topical hormonal compositions and methods for treatment
AU2001247893A1 (en) Method for facilitating commercial transactions
AU2001284865A1 (en) Methods for diagnosing and treating dysautonomia and other dysautonomic conditions
AU2001245977A1 (en) Method and composition for preventing or reducing the symptoms of menopause
AU2001273318A1 (en) Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disorders
AU2001251391A1 (en) Compositions and methods for promoting neural regeneration
AU2002221906A1 (en) Method for diagnosing allergic diseases
AU2001286750A1 (en) Compositions and methods for exon profiling
WO2003039490A9 (en) Compositions and methods for diagnosing and treating mental disorders
AU2001289123A1 (en) Compounds and methods for diagnosing and treating amyloid-related conditions
AU2001251507A1 (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
ZA200610474B (en) Compositions and methods for treating inflammatory disorders
AU4515001A (en) Compositions and methods for locally treating inflammatory diseases
AU2003301348A1 (en) Compositions and methods for diagnosing and treating autoimmune disease
AU2002229733A1 (en) Methods and reagents for treating autoimmune disorders
AU2003214920A1 (en) Methods and compositions for treating hematological disorders
AU2001251508A1 (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
AU2001256998A1 (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
AU2002227837A1 (en) Method and system for diagnosing andropause in males
AU2001238288A1 (en) Method and compositions for treating fibrotic diseases
AUPQ872800A0 (en) Compositions and methods for treating cardiovascular disorders